newsfilter
← Latest News
Business Wire·

enGene to Participate in Upcoming Investor Conferences

enGene Holdings Inc. (NASDAQ:ENGN), a clinical-stage, non-viral genetic medicines company, today announced that management will participate in the following investor conferences in November: Guggenheim 2nd Annual